Burns J W & Co. Inc. NY Has $2.20 Million Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Burns J W & Co. Inc. NY raised its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.8% in the 2nd quarter, according to the company in its most recent filing with the SEC. The firm owned 6,436 shares of the medical equipment provider’s stock after acquiring an additional 54 shares during the quarter. Burns J W & Co. Inc. NY’s holdings in Intuitive Surgical were worth $2,201,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in ISRG. HHM Wealth Advisors LLC increased its position in shares of Intuitive Surgical by 1,314.3% during the first quarter. HHM Wealth Advisors LLC now owns 99 shares of the medical equipment provider’s stock worth $25,000 after buying an additional 92 shares during the period. Bogart Wealth LLC increased its position in shares of Intuitive Surgical by 721.4% during the first quarter. Bogart Wealth LLC now owns 115 shares of the medical equipment provider’s stock worth $29,000 after buying an additional 101 shares during the period. Barrett & Company Inc. acquired a new stake in shares of Intuitive Surgical during the first quarter worth $30,000. Strategic Investment Solutions Inc. IL acquired a new stake in shares of Intuitive Surgical during the first quarter worth $39,000. Finally, Addison Advisors LLC boosted its stake in Intuitive Surgical by 1,837.5% during the first quarter. Addison Advisors LLC now owns 155 shares of the medical equipment provider’s stock worth $40,000 after acquiring an additional 147 shares in the last quarter. 82.91% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Intuitive Surgical

In related news, CEO Gary S. Guthart sold 50,314 shares of the business’s stock in a transaction that occurred on Friday, July 28th. The shares were sold at an average price of $326.76, for a total transaction of $16,440,602.64. Following the completion of the transaction, the chief executive officer now owns 17,186 shares of the company’s stock, valued at $5,615,697.36. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. In related news, CEO Gary S. Guthart sold 50,314 shares of the business’s stock in a transaction that occurred on Friday, July 28th. The shares were sold at an average price of $326.76, for a total transaction of $16,440,602.64. Following the completion of the transaction, the chief executive officer now owns 17,186 shares of the company’s stock, valued at $5,615,697.36. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director Amy L. Ladd sold 500 shares of the business’s stock in a transaction that occurred on Thursday, September 14th. The shares were sold at an average price of $305.68, for a total transaction of $152,840.00. Following the transaction, the director now directly owns 702 shares of the company’s stock, valued at approximately $214,587.36. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 60,309 shares of company stock valued at $19,649,321. Corporate insiders own 0.90% of the company’s stock.

Analyst Ratings Changes

ISRG has been the topic of several research analyst reports. Truist Financial increased their target price on shares of Intuitive Surgical from $347.00 to $400.00 in a research note on Wednesday, July 19th. Robert W. Baird initiated coverage on shares of Intuitive Surgical in a research note on Tuesday, July 18th. They issued an “outperform” rating and a $377.00 price objective on the stock. JPMorgan Chase & Co. raised their price objective on shares of Intuitive Surgical from $335.00 to $365.00 and gave the company an “overweight” rating in a research note on Friday, July 21st. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $360.00 price objective on shares of Intuitive Surgical in a research note on Thursday, August 17th. Finally, Raymond James raised their price target on shares of Intuitive Surgical from $323.00 to $368.00 and gave the company an “outperform” rating in a research report on Monday, July 24th. Five research analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $343.10.

Intuitive Surgical Stock Up 0.9 %

ISRG opened at $298.17 on Tuesday. The company has a market capitalization of $104.78 billion, a price-to-earnings ratio of 74.73, a PEG ratio of 4.15 and a beta of 1.30. The firm has a 50-day moving average price of $314.56 and a 200-day moving average price of $298.07. Intuitive Surgical, Inc. has a twelve month low of $180.07 and a twelve month high of $358.07.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Thursday, July 20th. The medical equipment provider reported $1.42 EPS for the quarter, beating the consensus estimate of $1.33 by $0.09. The company had revenue of $1.76 billion during the quarter, compared to analysts’ expectations of $1.74 billion. Intuitive Surgical had a net margin of 21.38% and a return on equity of 12.41%. Intuitive Surgical’s revenue for the quarter was up 15.4% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.85 earnings per share. On average, sell-side analysts expect that Intuitive Surgical, Inc. will post 4.53 earnings per share for the current fiscal year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.